Phase 1Completed
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males (DDI)
An Open-label Exploratory Study of the Pharmacokinetic Interaction of CXA-10 Administered to Steady State With Pravastatin and Vytorin® (Simvastatin and Ezetimibe) in Healthy Males
- Sponsor
- Complexa, Inc. (Industry)
- Enrollment
- 10 enrolled
- Conditions
- Acute Kidney Injury
- Interventions
- CXA-10; pravastatin; Vytorin® (combination of simvastatin and ezetimibe)
- Ages
- adults
- Registry
- NCT02547402
Full record on ClinicalTrials.gov
From the registry
This is an exploratory study in a small, well controlled group of healthy subjects to explore the effect of CXA-10 on pravastatin and Vytorin® (combination of simvastatin and ezetimibe).
Primary outcomes
- Maximum Plasma Concentration [Cmax]
History
Last registry update
Study completion
Primary completion
Started
Registered